JP2017513849A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513849A5 JP2017513849A5 JP2016562764A JP2016562764A JP2017513849A5 JP 2017513849 A5 JP2017513849 A5 JP 2017513849A5 JP 2016562764 A JP2016562764 A JP 2016562764A JP 2016562764 A JP2016562764 A JP 2016562764A JP 2017513849 A5 JP2017513849 A5 JP 2017513849A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- fragment
- variant
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014901382 | 2014-04-15 | ||
| AU2014901382A AU2014901382A0 (en) | 2014-04-15 | Group a streptococcal vaccine | |
| AU2014903042 | 2014-08-06 | ||
| AU2014903042A AU2014903042A0 (en) | 2014-08-06 | Group a streptococcal vaccine | |
| AU2014904453A AU2014904453A0 (en) | 2014-11-05 | Group a streptococcal vaccine | |
| AU2014904453 | 2014-11-05 | ||
| PCT/AU2015/050174 WO2015157820A1 (en) | 2014-04-15 | 2015-04-15 | Group a streptococcus vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020201171A Division JP7072921B2 (ja) | 2014-04-15 | 2020-12-03 | Ａ群レンサ球菌ワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017513849A JP2017513849A (ja) | 2017-06-01 |
| JP2017513849A5 true JP2017513849A5 (enExample) | 2018-04-26 |
Family
ID=54323282
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562764A Pending JP2017513849A (ja) | 2014-04-15 | 2015-04-15 | Ａ群レンサ球菌ワクチン |
| JP2020201171A Active JP7072921B2 (ja) | 2014-04-15 | 2020-12-03 | Ａ群レンサ球菌ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020201171A Active JP7072921B2 (ja) | 2014-04-15 | 2020-12-03 | Ａ群レンサ球菌ワクチン |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10301362B2 (enExample) |
| EP (1) | EP3131575B1 (enExample) |
| JP (2) | JP2017513849A (enExample) |
| KR (2) | KR102744193B1 (enExample) |
| CN (1) | CN106794236B (enExample) |
| AU (1) | AU2015246654B2 (enExample) |
| BR (1) | BR112016023915B1 (enExample) |
| CA (1) | CA2945052C (enExample) |
| DK (1) | DK3131575T3 (enExample) |
| IL (1) | IL248266B (enExample) |
| MX (1) | MX392514B (enExample) |
| MY (1) | MY191217A (enExample) |
| NZ (1) | NZ725212A (enExample) |
| SG (1) | SG11201608380PA (enExample) |
| WO (1) | WO2015157820A1 (enExample) |
| ZA (1) | ZA201607355B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017513849A (ja) | 2014-04-15 | 2017-06-01 | グリフィス・ユニバーシティＧｒｉｆｆｉｔｈ Ｕｎｉｖｅｒｓｉｔｙ | Ａ群レンサ球菌ワクチン |
| CN106606775A (zh) * | 2015-10-27 | 2017-05-03 | 格里菲斯大学 | 脂质体a群链球菌疫苗 |
| TWI598360B (zh) * | 2016-12-19 | 2017-09-11 | 義守大學 | Ｆｓｂｍ重組蛋白及其用途 |
| WO2019036761A1 (en) * | 2017-08-23 | 2019-02-28 | Griffith University | IMMUNOGENIC PEPTIDE DIRECTED AGAINST GROUP A STREPTOCOCCUS |
| CN110776508B (zh) * | 2018-07-27 | 2021-07-16 | 海创药业股份有限公司 | 一种brd4抑制剂及其制备方法和用途 |
| KR102437436B1 (ko) * | 2019-04-26 | 2022-08-30 | 주식회사 엠디헬스케어 | 스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도 |
| NL2023863B1 (en) | 2019-09-20 | 2021-05-25 | Univ Griffith | Protein particles and uses thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047238A (en) | 1983-06-15 | 1991-09-10 | American Home Products Corporation | Adjuvants for vaccines |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5811105A (en) | 1987-12-23 | 1998-09-22 | Glaxo Wellcome, Inc. | Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway |
| US5785973A (en) | 1988-02-01 | 1998-07-28 | Praxis Biologics, Inc. | Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines |
| GB8912330D0 (en) | 1989-05-30 | 1989-07-12 | Wellcome Found | Live vaccines |
| GB9007194D0 (en) | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
| AUPM885194A0 (en) * | 1994-10-14 | 1994-11-10 | Council Of The Queensland Institute Of Medical Research, The | Synthetic peptides and vaccines comprising same |
| AUPO007396A0 (en) | 1996-05-24 | 1996-06-20 | Csl Limited | Ebv ctl epitopes |
| AUPO784197A0 (en) | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
| US7838010B2 (en) * | 2004-10-08 | 2010-11-23 | Novartis Vaccines And Diagnostics S.R.L. | Immunogenic and therapeutic compositions for Streptococcus pyogenes |
| EP1879613B1 (en) * | 2005-05-05 | 2011-11-30 | Merck Sharp & Dohme Corp. | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
| US8623356B2 (en) | 2005-11-29 | 2014-01-07 | The University Of Sydney | Demibodies: dimerization-activated therapeutic agents |
| US8529911B2 (en) * | 2006-07-07 | 2013-09-10 | Intercell Austria Ag | Small Streptococcus pyogenes antigens and their use |
| US20090010929A1 (en) * | 2006-12-04 | 2009-01-08 | Good Michael F | Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates |
| US8482298B2 (en) | 2006-12-18 | 2013-07-09 | Schrader Electronics Ltd. | Liquid level and composition sensing systems and methods using EMF wave propagation |
| US8287885B2 (en) * | 2007-09-12 | 2012-10-16 | Novartis Ag | GAS57 mutant antigens and GAS57 antibodies |
| US20090162369A1 (en) * | 2007-12-12 | 2009-06-25 | Katin Helena Threse Nordstrom | Synthetic chimeric peptides |
| DK2344523T3 (da) * | 2008-09-17 | 2016-04-18 | Glaxosmithkline Biolog Sa | Gas-kombinationsvacciner og lægemidler |
| JP2017513849A (ja) | 2014-04-15 | 2017-06-01 | グリフィス・ユニバーシティＧｒｉｆｆｉｔｈ Ｕｎｉｖｅｒｓｉｔｙ | Ａ群レンサ球菌ワクチン |
| WO2019036761A1 (en) * | 2017-08-23 | 2019-02-28 | Griffith University | IMMUNOGENIC PEPTIDE DIRECTED AGAINST GROUP A STREPTOCOCCUS |
-
2015
- 2015-04-15 JP JP2016562764A patent/JP2017513849A/ja active Pending
- 2015-04-15 KR KR1020237007349A patent/KR102744193B1/ko active Active
- 2015-04-15 CA CA2945052A patent/CA2945052C/en active Active
- 2015-04-15 AU AU2015246654A patent/AU2015246654B2/en active Active
- 2015-04-15 KR KR1020167031477A patent/KR102730367B1/ko active Active
- 2015-04-15 SG SG11201608380PA patent/SG11201608380PA/en unknown
- 2015-04-15 CN CN201580027379.8A patent/CN106794236B/zh active Active
- 2015-04-15 EP EP15779482.7A patent/EP3131575B1/en active Active
- 2015-04-15 BR BR112016023915-6A patent/BR112016023915B1/pt active IP Right Grant
- 2015-04-15 WO PCT/AU2015/050174 patent/WO2015157820A1/en not_active Ceased
- 2015-04-15 MY MYPI2016001815A patent/MY191217A/en unknown
- 2015-04-15 NZ NZ725212A patent/NZ725212A/en unknown
- 2015-04-15 DK DK15779482.7T patent/DK3131575T3/da active
- 2015-04-15 MX MX2016013277A patent/MX392514B/es unknown
- 2015-04-15 US US15/304,462 patent/US10301362B2/en active Active
-
2016
- 2016-10-09 IL IL248266A patent/IL248266B/en unknown
- 2016-10-25 ZA ZA2016/07355A patent/ZA201607355B/en unknown
-
2019
- 2019-04-30 US US16/398,598 patent/US10513544B2/en active Active
-
2020
- 2020-12-03 JP JP2020201171A patent/JP7072921B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513849A5 (enExample) | ||
| Turner et al. | Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi | |
| JP2015501656A5 (enExample) | ||
| JP2013520487A5 (enExample) | ||
| JP2018537087A5 (enExample) | ||
| JP7072921B2 (ja) | Ａ群レンサ球菌ワクチン | |
| JP2018509935A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| JP2013523718A5 (enExample) | ||
| EP3279217B1 (en) | Streptococcus pneumoniae protein antigen, and preparation method and use thereof | |
| HRP20161305T1 (hr) | Liječenje mikrobnih infekcija | |
| JP2015514132A5 (enExample) | ||
| WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
| JP2017511133A5 (enExample) | ||
| JP2018537089A5 (enExample) | ||
| US20080095756A1 (en) | Compositions Comprising Lysostaphin Variants And Methods Of Using The Same | |
| JP2020509770A5 (enExample) | ||
| JP2015513314A5 (enExample) | ||
| CN116262781B (zh) | 抗菌肽defensin衍生物及其原核表达方法与应用 | |
| Zhang et al. | The tissue factor pathway inhibitor 1 of Sciaenops ocellatus possesses antimicrobial activity and is involved in the immune response against bacterial infection | |
| JP2020127419A5 (enExample) | ||
| JP2019531100A5 (enExample) | ||
| Banks et al. | Streptococcus sanguis secretes CD14-binding proteins that stimulate cytokine synthesis: a clue to the pathogenesis of infective (bacterial) endocarditis? | |
| Grishin et al. | Defensins are natural peptide antibiotics of higher eukaryotes | |
| JP2009507474A5 (enExample) |